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Ampullary Carcinoid: A Case Report
Patrick Hickey, DO, Shashin Shah, MD and Hiral Shah, MD
Lehigh Valley Health Network, Allentown, Pennsylvania

CONCLUSION

CASE PRESENTATION

BACKGROUND
•	Carcinoid tumors of the Ampulla of Vater
are rare low-grade, well differentiated
tumors.
•	They account for less than 1% of all
gastrointestinal neuroendocrine tumors
(NETs) and less than 2% of all tumors in
1
the ampullary region.
•	The most common presenting
symptoms are jaundice and nonspecific abdominal discomfort.

•	A 52 year old female presented with two years of epigastric pain and weight loss. The pain was predominantly nocturnal and associated
with cramping. It would wake her from sleep, and cause nausea and vomiting. A trial of PPI was ineffective.
•	CT Scan Abdomen and Pelvis: Abnormal round enhancing lesion in the ampullary region measuring 16mm with dilation of the
extrahepatic biliary system.
• EGD: Confirmed a subepithelial appearing ampullary mass. Biopsy was negative for adenoma.
•	EUS: Given the clinical suspicion for malignancy she underwent EUS. Showed a subepithelial ampullary mass measuring 18mm in
diameter without bile duct obstruction. The mass was hypoechoic, with a thick rimmed submucosal border. Fine needle biopsies using 19
and 22-guage shark core needles were obtained. Cytology was diagnostic for ampullary carcinoid.
•	Cytology: Showed the tumor was AE1/AE3 positive, CD45 negative, synaptophysin positive, chromogranin negative, CD56 positive, and
Ki-67 involving <5% of tumor cells confirming a well-differentiated neuroendocrine tumor (typical carcinoid tumor).
•	She underwent duodenotomy with resection of ampullary tumor, and biliary sphicteroplasty by surgical oncology.
•	Pathology: Neuroendocrine tumor, well differentiated (carcinoid tumor) 1.5 x 1.4 x 1.0 cm greatest dimensions, ampulla of Vater. Tumor
predominantly involves duodenal wall, duodenal submucosa and focally duodenal mucosa. Tumor focally involves deep margin of resection
and focally involves lateral margin of resection. TNM tumor stage: pT2, pNX.
•	A repeat EUS was performed four months after surgery with no evidence of residual lesion, and biopsies of the involved site were normal.

•	The recognition of these tumors is
important, as historically patients with
ampullary NETs have been more likely
to develop metastases at smaller sizes
and higher mortality than patients with
2
duodenal NETs.

•	NETs are low-grade endocrine cell tumors of the GI tract which rarely
occur in the ampulla of Vater.
•	The small number of documented cases limits the knowledge on their
presentation and behavior.
•	The most common method of diagnosis is EGD with biopsies, which
3
can be followed by EUS to assess local invasion.
•	Pathologic findings consist of medium size cells with eosinophilc
cytoplasm and central round nuclei with mild atypia and
immunohistochemistry may show expression of chromogranin,
4
synaptophysin, gastrin, somatostatin and/or neuron specific enolase.
•	Treatment is generally surgical resection of tumor and involved lymph
nodes.
•	Radical surgical resection with pancreaticoduodenectomy appears to
be the appropriate treatment of ampullary carcinoids regardless of
4
size.
•	It is important to keep this clinical entity in working differential
diagnoses of abdominal pain and jaundice.
•	As seen in our case EGD biopsies may be unrevealing necessitating
further evaluation with EUS and core biopsies for definitive diagnosis.
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•	We present a case of ampullary
carcinoid found in a patient with nonspecific abdominal pain.
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Figure 1: CT of the Abdomen and Pelvis showing
an abnormal round enhancing lesion in the
ampullary region possibly measuring up to 16 mm.
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